跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,121 条关于
“Nippon Express Taiwan”
全部
3,121
临床试验
1,505
药物
92
机构
112
资讯
1,412
去年
NX Taiwan Achieves Historic Medical Device QMS Certification, First Among Japanese Companies
去年
Amaran Biotech Partners with Nippon Fine Chemical to Advance Nanoparticle-Based Drug Manufacturing
去年
Nippon Shinyaku’s DMD Drug Fails Confirmatory Trial
去年
Atsena Therapeutics and Nippon Shinyaku Partner to Advance Gene Therapy for LCA1
去年
REGENXBIO and Nippon Shinyaku Partner to Advance Gene Therapies for MPS I and MPS II
5个月前
GlycoNex Partners with Nippon Kayaku to Develop Tumor-Activated ADC GNX201 for Solid Tumors
去年
AB2 Bio and Nippon Shinyaku Strike $686M Deal for Rare Disease Drug Tadekinig Alfa
去年
AstraZeneca to Launch Palivizumab (Synagis) in India for RSV Prevention
上个月
Nippon Shinyaku Exercises Option for AB2 Bio's Tadekinig Alfa, Securing U.S. Commercialization Rights for Rare Autoinflammatory Diseases
2个月前
Elixirgen Therapeutics and Nippon Shinyaku Enter Option Agreement for Full-Length Dystrophin mRNA Therapy EXG-7001 in Duchenne Muscular Dystrophy
第 1 页,共 142 页
上一页
下一页